Related references
Note: Only part of the references are listed.Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
AKT2 is essential to maintain podocyte viability and function during chronic kidney disease
Guillaume Canaud et al.
NATURE MEDICINE (2013)
A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies
Kristi L. Allen et al.
BLOOD (2012)
Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity
Dudley W. Lamming et al.
SCIENCE (2012)
Examining How Antiphospholipid Antibodies Activate Intracellular Signaling Pathways: A Systematic Review
Katie Poulton et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2012)
Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta 2GPI and apoER2
Sangeetha Ramesh et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Role of mTOR in podocyte function and diabetic nephropathy in humans and mice
Markus Goedel et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin
Kostas Stylianou et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Calcineurin Inhibitor-Induced and Ras-Mediated Overexpression of VEGF in Renal Cancer Cells Involves mTOR through the Regulation of PRAS40
Aninda Basu et al.
PLOS ONE (2011)
PDGF-BB and TGF-β1 on cross-talk between endothelial and smooth muscle cells in vascular remodeling induced by low shear stress
Ying-Xin Qi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies
G. Canaud et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Matthew R. Janes et al.
NATURE MEDICINE (2010)
Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease
Andreas L. Serra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effect of Antibodies on Endothelium
X. Zhang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Morbidity and mortality in the antiphospholipid syndrome
Gerard Espinosa et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Endothelin-1 signalling in vascular smooth muscle: Pathways controlling cellular functions associated with atherosclerosis
Melanie E. Ivey et al.
ATHEROSCLEROSIS (2008)
The role of anti phospholipid syndrome in cardiovascular disease
Brian R. Long et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2008)
Late Onset Antibody-Mediated Rejection and Endothelial Localization of Vascular Endothelial Growth Factor Are Associated With Development of Cardiac Allograft Vasculopathy
Julianne Bayliss et al.
TRANSPLANTATION (2008)
AKT/PKB signaling: Navigating downstream
Brendan D. Manning et al.
CELL (2007)
Anti-β2-glycoprotein I antibodies in complex with β2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V
Tong Shi et al.
ARTHRITIS AND RHEUMATISM (2006)
Phosphorylated S6 ribosomal protein: A novel biomarker of antibody-mediated rejection in heart allografts
E. J. Lepin et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
B de Laat et al.
BLOOD (2006)
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies - Prevalence, clinical associations, and long-term outcome
MG Tektonidou et al.
ARTHRITIS AND RHEUMATISM (2004)
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
HJ Eisen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Co-culture of endothelial cells and smooth muscle cells affects gene expression of angiogenic factors
S Heydarkhan-Hagvall et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Medical progress: The antiphospholipid syndrome.
JS Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Sustained suppression of neointimal proliferation by sirolimus-eluting stents - One-year angiographic and intravascular ultrasound follow-up
JE Sousa et al.
CIRCULATION (2001)